| Characteristic | Private investors | Strategic investors | Equal interest |
|---|---|---|---|
| CROs, specialty CROs/patient recruitment specialists, virtual clinical trial specialists, clinical research sites, data and analytic services or technology/software | 45% | 22% | 33% |
| Medical communications services or technology/software, commercialization services or technology/software | 48% | 19% | 33% |
| CDMOs, supply chain services or technology/software | 43% | 23% | 33% |
| Diagnostic lab services | 19% | 44% | 38% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
March 2021
More information
Region
United States
Survey time period
November 19, 2020, to December 30, 2020
Number of respondents
286 respondents
Special properties
U.S. healthcare and life sciences investment professionals
Supplementary notes
Percentage points missing/exceeding 100 percent are probably due to rounding.
Citation formats
